Best practice

Tailored strategy to reach more patients in sub-Saharan Africa

Novartis is the only company to explicitly tailor an access-to-medicine strategy to countries facing a high burden of disease.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |